Aptorum Group Limited Interview to Air on Bloomberg U.S. on

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology

Related Keywords

United States , Singapore , Darren Lui , Ghislaine Gasparetto , Aptorum Group Form , Aptorum Group Or , Technologies Pte Ltd , Investor Relations Department , Singapore Agency For Science , Actifin Financial Communications Europe , Redchip Financial Communications United States , Daptorum Group , Aptorum Group Limited Nasdaq , Regulatory News , Group Limited , Euronext Paris , Redchip Money Report , Accelerate Technologies Pte Ltd , Aptorum Group Limited , Securities Litigation Reform Act , French Autorit , Des March , Regulations Delegated , Relations Department , Financial Communications United States , Financial Communications Europe , Aptorum , Group , Imited , Interview , Bloomberg , Redchip , Money , Report ,